Aclaris Therapeutics (ACRS) Stock Chart & Stock Price History $2.60 +0.03 (+1.17%) Closing price 04:00 PM EasternExtended Trading$2.64 +0.04 (+1.73%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aclaris Therapeutics Stock Price Performance 5 Day Performance+2.99%1 Month Performance-4.96%3 Month Performance+113.64%6 Month Performance+95.83%Year-To-Date Performance+4.23%1 Year Performance+126.75% Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ACRS Stock Chart for Tuesday, January, 21, 2025 ACRS Chart by TradingView Aclaris Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/20/2025$2.57$2.57$2.59$2.46506,026 shs$183.58 million01/17/2025$2.51$2.57+2.39%$2.59$2.46506,026 shs$183.58 million01/16/2025$2.51$2.51$2.53$2.44378,510 shs$179.29 million01/15/2025$2.50$2.51+0.40%$2.57$2.42516,113 shs$179.29 million01/14/2025$2.48$2.50+0.81%$2.50$2.312.69 million shs$178.58 million01/13/2025$2.47$2.48+0.40%$2.49$2.382.16 million shs$177.15 million01/10/2025$2.46$2.47+0.41%$2.47$2.321.66 million shs$176.44 million01/09/2025$2.46$2.46$2.51$2.40635,036 shs$175.72 million01/08/2025$2.50$2.46-1.60%$2.51$2.40635,036 shs$175.72 million01/07/2025$2.53$2.50-1.19%$2.60$2.43531,298 shs$178.58 million Get the Latest News and Ratings for ACRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/06/2025$2.60$2.53-2.69%$2.65$2.45843,754 shs$180.72 million01/03/2025$2.48$2.60+4.84%$2.80$2.491.04 million shs$185.72 million01/02/2025$2.48$2.48$2.62$2.48501,373 shs$177.15 million01/01/2025$2.48$2.48$2.65$2.35909,671 shs$177.15 million12/31/2024$2.48$2.48$2.65$2.35909,671 shs$177.15 million12/30/2024$2.73$2.48-9.16%$2.74$2.47786,907 shs$177.15 million12/27/2024$2.91$2.73-6.19%$2.97$2.71550,799 shs$195.01 million12/26/2024$2.90$2.91+0.34%$3.02$2.80758,222 shs$207.86 million12/25/2024$2.90$2.90$2.96$2.84499,772 shs$207.15 million12/24/2024$2.89$2.90+0.35%$2.96$2.84499,772 shs$207.15 million12/23/2024$2.72$2.89+6.25%$3.12$2.841.79 million shs$206.44 million12/20/2024$2.77$2.72-1.81%$2.90$2.711.16 million shs$194.29 million Related Companies Prothena Stock Chart Bicara Therapeutics Stock Chart CorMedix Stock Chart uniQure Stock Chart 89bio Stock Chart Dianthus Therapeutics Stock Chart Cullinan Therapeutics Stock Chart Pharming Group Stock Chart Arbutus Biopharma Stock Chart LENZ Therapeutics Stock Chart Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRS) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
